Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TYG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,756
Award facts
- Contract value 100% obligated
- $18,756.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,756.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL configuration on January 20, 2026, with completion expected by January 21, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency and other military treatment facilities. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, including rheumatologic treatments such as Cosentyx. The firm fixed-price delivery order structure and competitive award process reflect AmerisourceBergen's established position as a qualified provider within the federal medical supply chain serving the Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3TYG?
SPE2DR26F3TYG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F3TYG worth?
The government has obligated $18,756 on SPE2DR26F3TYG.
Is contract SPE2DR26F3TYG an order under another contract?
Yes. SPE2DR26F3TYG is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TYG competed?
The extent of competition for SPE2DR26F3TYG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award